JUN 02, 2021 8:00 AM PDT

Exploiting digital histology approaches to probe the pathophysiology of SARS-CoV-2 infection

Sponsored by: Leica Biosystems
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract
Date:  June 2, 2021
Time: 8:00am (PDT),  11:00am (EDT)
 
COVID-19 is a complex multi-phase disease. In most people an early innate immune response transitions into a broadly effective adaptive immune response that controls the virus. However, 20-30% of symptomatic patients require hospitalisation, with ICU admission rates ranging from 4.9-11.5%, and overall fatality rates of around 0.5%. Long-term inflammation in patients receiving supportive care in ICU can lead to pulmonary fibrosis, representing a third phase of the disease.
 
The success of broad-acting immunosupressants such as dexamethasome clearly demonstrates that while the immune system is involved in disease amelioration it also causes disease exacerbation. Understanding what factors underpin the transition between each phase in the lungs, the site of primary infection, and other organs is required for full understanding of the pathophysiology of SARSCoV-2. Through various researches, our ultimate goal is to inform the optimal selection and scheduling of therapeutic approaches. To achieve this we have undertaken a wide ranging analysis of post-mortem samples from patients at the different stages of COVID-19 disease. Selected results will be presented during the talk.
 
The talk will also cover a range of digital pathology and tissue multiplexing techniques, discuss differences in capabilities of specific research platforms and how they can be effectively combined to probe the biology of the tissue microenvironment.
 
Learning Objectives
  • Describe different techniques involved in molecular histology and how they integrate in a workflow.
  • Identify the pathophysiology of SARS-CoV2 infection in tissues, including related to viral replication and anti-viral immunity.
  • Demonstrate how digital image analyses (immunofluorescence, transcriptomic) can be utilised to determine features of microenvironmental immunity.
 
For Research Use Only. Not for Use in Diagnostic Procedures
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
Loading Comments...
Show Resources